Abstract：【Objective】 To explore serum levels of uric acid (UA), interleukin-6 (IL-6) and ferritin (SF) in patients with nonalcoholic fatty liver disease (NAFLD) and their clinical significances. 【Methods】 The clinical data of 82 patients with NAFLD admitted to our hospital from May 2016 to March 2018 were divided into the mild NAFLD group (n=27) and the moderate NAFLD group (n=34) and the severe NAFLD group (n=21). At the same time, 30 healthy subjects were selected as the control group. Serum levels of UA, IL-6, SF, blood lipids [total cholesterol (TC), triglycerides (TG)], liver function [aspartate aminotransferase (AST), alanine aminotransferase (ALT)] and insulin resistance [fasting plasma glucose (FBG), fasting Insulin (FINS), insulin resistance index (HOMA-IR)] were measured in all patients. 【Results】 Serum TG, TC,AST, ALT, UA, IL-6 levels in the NAFLD group were significant higher than those in the control group (P<0.05). Serum FBG, FINS,UA, IL-6 levels and HOMA-IR in the moderate and severe NAFLD groups were significant higher than those in the mild NAFLD group and the control group (P<0.05). The HOMA-IR value in the severe NAFLD group was significant higher than that in the moderate NAFLD group (P<0.05). Pearson correlation analysis showed that serum UA levels in cases with NAFLD were positively correlated with BMI (r=2.572), FINS (r=0.244) and HOMA-IR (r=2.730) (P<0.05) and serum IL-6 levels were positively correlated with BMI (r=2.375), ALT (r=2.728) and HOMA-IR (r=0.254) (P<0.05). It also showed that serum SF content was positively correlated with BMI (r=0.285), ALT (r=0.372), FINS (r=0.243), and HOMA-IR (r=0.274) (P<0.05). IL-6 was positively correlated with SF (r=0.304, P<0.05).【Conclusion】 Serum UA, IL-6 and SF levels in NAFLD patients were abnormally high, which were closely related to the severity of the disease and also highly correlated with insulin resistance.
刘晓红, 李文华, 蒋淑杰. 非酒精性脂肪性肝病患者血清UA、IL-6、SF水平变化及其临床意义[J]. 医学临床研究, 2019, 36(1): 55-58.
LIU Xiao-hong, LI Wen-hua, JIANG Shu-jie. Serum Levels and Clinical Significances of UA, IL-6 and SF in Patients with Nonalcoholic Fatty Liver Disease. JOURNAL OF CLINICAL RESEARCH, 2019, 36(1): 55-58.
[1] Younossi ZM, Koenig AB, Abdelatif D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta‐analytic assessment of prevalence, incidence, and outcomes[J].Hepatology,2016, 64 (1): 73-84. [2] Yan J, Xie W, Ou WN, et al. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China [J].J Gastroenterol Hepatol,2013, 28 (10): 1654-1659. [3] 徐承富,厉有名.非酒精性脂肪性肝病与高尿酸血症[J].实用肝脏病杂志,2017,20(3):260-262. [4] 邢英,郑嵘炅,李雅丽,等.白细胞介素-6、肿瘤坏死因子-α在非酒精性脂肪肝中的水平变化及与HOMA-IR关系分析[J].现代中西医结合杂志,2017,26(9):932-934. [5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166. [6] Braga F, Pasqualetti S, Ferraro S, et al. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis [J].Clin Chem Lab Med,2016, 54 (1): 7-15. [7] Gong S, Song J, Wang L, et al. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis[J].Eur J Gastroenterol Hepatol,2016,28(2):132-138. [8] 范能光,彭亮,夏振华,等.正常血清尿酸与非酒精性脂肪性肝病的相关性研究[J].中国糖尿病杂志,2017,25(11):970-973. [9] 厉有名.非酒精性脂肪性肝病与高尿酸血症相互关系的研究现状及展望[J].中华肝脏病杂志,2016,24(2):89-91. [10] Jaruvongvanich V, Ahuja W, Wijarnpreecha K, et al. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis [J].Eur J Gastroenterol Hepatol,2017, 29 (6): 1. [11] 吴林林,龚伟,吴钢,等.血浆微量元素与非酒精性脂肪性肝病的相关性[J].江苏医药,2017,43(5):311-314. [12] Barton JC, Barton JC, Acton RT, et al. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at Diagnosis [J].Clin Gastroenterol Hepatol,2012, 10 (4): 412-416. [13] 欧强,王洋,徐燕华,等.非酒精性脂肪性肝病患者血清铁代谢指标的变化及临床意义[J].临床肝胆病杂志,2016,32(12):2360-2363.
2019, Vol. 36 
